José Luis Domínguez-Escrig

Dr José Luis Domínguez-Escrig is a consultant urologist with extensive clinical and research experience in uro-oncology, particularly in the diagnosis and treatment of bladder cancer and upper urinary tract cancer. He is currently Head of Urology at the Ascires Group, where he combines clinical practice with research activity.

He graduated in Medicine and Surgery in Valencia in 1994 and continued his postgraduate training in the United Kingdom. After completing his specialist training, he obtained the title of Member of the Royal College of Surgeons of England in 2001 and later became a Fellow of the Royal College of Surgeons in Urology in 2009, consolidating his career in the field of oncological urology.

Between 2004 and 2006, he carried out research at the Northern Institute for Cancer Research at Newcastle University, where he developed a research project focused on new therapeutic strategies in urological cancer. As a result of this work, he completed his doctoral thesis entitled “Tyrosine Kinase and Farnesyltransferase Inhibitors: Potential Selective Targeted Therapy in Bladder Cancer”, obtaining his PhD in Medicine in 2006.

In the scientific field, he has an outstanding research profile, with more than 130 publications in national and international journals, and serves as a reviewer for specialised journals including Actas Urológicas Españolas, BJU International, Urologic Oncology, European Urology Focus and The Journal of Urology. He has also presented his work at numerous leading international congresses and scientific meetings, including AACR, AUA, EAU, BAUS, SIU and AEU.

His research activity focuses on the development of new therapeutic strategies in uro-oncology, participating as principal investigator in clinical trials related to bladder and prostate cancer, as well as in translational research projects aimed at improving the personalisation of oncological treatment.

Dr José Luís Domínguez is an expert in focal therapy with IRE (Irreversible Electroporation), serves as an AngioDynamics trainer and mentor for Europe and South America in IRE, and is a founding member of the Spanish Focal Therapy Group (getFocal).

He also maintains an active role within international scientific societies and organisations. He is a member of the drafting panel for the European Urology Guidelines on bladder cancer and upper urinary tract cancer, a member of the CUETO Group, Professor at the European School of Urology, Spanish Delegate to the European Board of Urology (EBU) and member of its examination committee. In addition, since 2004 he has served as Secretary of the Executive Committee of the EBU.

His main clinical interests include urothelial carcinoma of the bladder and upper urinary tract, as well as the development and evaluation of focal therapies in uro-oncology, with the aim of providing personalised treatments based on the latest advances in oncological medicine.